RADIATION THERAPY (RT) AND TEMOZOLAMIDE (TMZ) AS ADJUVANT THERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM). PRELIMINARY DATA

被引:0
|
作者
Iodice, G. [1 ]
Fusco, V. [2 ]
Tartarone, A. [1 ]
Bochicchio, A. M. [1 ]
Capobianco, A. [1 ]
Coccaro, M. R. [1 ]
Di Leo, P. [1 ]
Romano, G. P. [1 ]
Castaldo, G. [2 ]
Montagna, A. [2 ]
Lapadula, L. [2 ]
机构
[1] Ctr Riferimento Oncol, Hematol Oncol Unit, Rionero In Vulture, PZ, Italy
[2] Ctr Riferimento Oncol, Radiotherapy Unit, Rionero In Vulture, PZ, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:87 / 87
页数:1
相关论文
共 50 条
  • [1] Intra-carotid chemo (ICC) followed by radiation (RT) with concomitant temozolamide (TMZ) and subsequent maintenance TMZ therapy in patients (pts) with glioblastoma multiforme (GBM).
    Mohin, G.
    Davis, R.
    Meek, A.
    Rosiello, A.
    Roque, C.
    Hentschel, P.
    Roche, P.
    Manzione, J.
    Vacirca, J.
    Madajewicz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 71S - 71S
  • [2] RADIOTHERAPY (RT) AND TEMOZOLAMIDE (TMZ) IN RESECTED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) : A TEN YEARS OF EXPERIENCE AT SINGLE INSTITUTION
    Ziccarelli, P.
    Cervo, E.
    Indrieri, P.
    Piro, F.
    Siciliano, R.
    Ziccarelli, L.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S215 - S216
  • [3] Phase I trial of erlotinib with radiation therapy (RT) in patients with glioblastoma multiforme (GBM)
    Krishnan, S
    Brown, P
    Ballman, K
    Fiveash, J
    Uhm, J
    Giannini, C
    Geoffroy, F
    Nabors, L
    Buckner, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 117S - 117S
  • [4] A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM)
    Brown, P. D.
    Krishnan, S.
    Sarkaria, J.
    Wu, W.
    Mischel, P.
    Yong, W. H.
    Arusell, R.
    Jenkins, R. B.
    Buckner, J. C.
    Giannini, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, Nicholas A.
    Lamborn, Kathleen L.
    Polley, Mei-Yin C.
    Hsieh, Emily
    Kivett, Valerie
    Page, Margaretta S.
    Parvataneni, Rupa
    Nicol, Steve
    Thornton, Don
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
  • [6] Retrospective analysis of glioblastoma multiforme (GBM) patients treated initially with BCNU compared to temozolomide (TMZ) with concomitant radiation therapy
    Vinjamuri, M.
    Adumala, R.
    Altaha, R.
    Hobbs, J.
    Crowell, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
    Sarkaria, J. N.
    Galanis, E.
    Wu, W.
    Giannini, C.
    Jaeckle, K. A.
    Doyle, L.
    Uhm, J.
    Brown, P.
    Dietz, A. B.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM)
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Herndon, J. E.
    Marcello, J.
    Bailey, L.
    Threatt, S.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Safety and efficacy of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed by BV, TMZ, and irinotecan (CPT-11) for newly diagnosed glioblastoma multiforme (GBM)
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Herndon, J. E., II
    Kirkpatrick, J.
    Gururangan, S.
    Bailey, L.
    Friedman, A. H.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Results of a Phase 2 Clinical Trial of Neo-Adjuvant Temozolomide (TMZ), Followed by Concurrent TMZ and Hypofractionated Accelerated External Beam Radiation Therapy (Ac-EBRT) With Limited Margins, and Adjuvant TMZ for Patients With Glioblastoma Multiforme (GBM)
    Shenouda, G.
    Souhami, L.
    Panet-Raymond, V.
    Abdulkarim, B.
    Cury, F.
    Owen, S.
    Kavan, P.
    Petrecca, K.
    Guiot, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S160 - S160